Off-label medication use in frontotemporal dementia.
Off-label medication use in frontotemporal dementia.
复制标题
DOI:
10.1177/1533317509356692
复制
发表时间:
2010-03
期刊:
影响因子:
--
通讯作者:
Boxer AL
中科院分区:
文献类型:
--
作者:
Bei Hu;Ross L;Neuhaus J;Knopman D;Kramer J;Boeve B;Caselli RJ;Graff-Radford N;Mendez MF;Miller BL;Boxer AL
There are no Food and Drug Administration (FDA)-approved medications indicated for the treatment of frontotemporal dementia (FTD). We sought to determine the most commonly used drugs used to treat behavioral variant FTD (bvFTD) in specialized dementia clinics. Medication and demographic data from the Alzheimer’s Disease Research Centers of California (ARCC) and a multicenter FTD natural history study (NHS) data set were compared in bvFTD and Alzheimer’s disease (AD), and effects of demographic variables were assessed using logistic regression. Overall, the percentage of patients taking one or more FDA-approved AD or psychiatric medications was similar in bvFTD and AD; however, after controlling for demographic variables, acetylcholinesterase inhibitor (AChI) use was less common in bvFTD, whereas memantine use remained similar in the 2 groups. Despite lack of evidence for efficacy, the use of AChIs and memantine is common in bvFTD. Clinical trials should be pursued to determine the optimal therapeutic interventions for bvFTD.
登录
查看更多内容
影响因子:
15.1
作者:
Bewick, V;Cheek, L;Ball, J
通讯作者:
Ball, J
影响因子:
2.8
作者:
Ballard, Clive;Day, Sarah;Sorensen, Susanne
通讯作者:
Sorensen, Susanne
影响因子:
2.1
作者:
Swanberg, Margaret M.
通讯作者:
Swanberg, Margaret M.
影响因子:
4
作者:
Diehl-Schmid, Janine;Foerstl, Hans;Kurz, Alexander
通讯作者:
Kurz, Alexander
影响因子:
2.4
作者:
Kertesz, A.;Morlog, D.;Brashear, R.
通讯作者:
Brashear, R.